S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:ORMP

Oramed Pharmaceuticals SEC Filings & 10K Form

$8.91
-0.04 (-0.45 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.50
Now: $8.91
$9.43
50-Day Range
$4.31
MA: $7.74
$11.33
52-Week Range
$2.40
Now: $8.91
$11.71
Volume340,832 shs
Average Volume752,549 shs
Market Capitalization$261.69 million
P/E RatioN/A
Dividend YieldN/A
Beta1.98

SEC Filings

Oramed Pharmaceuticals (NASDAQ:ORMP) SEC Filings

DateFilerForm TypeView
02/17/2021
3:21 PM
Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2021
11:15 PM
Oramed Pharmaceuticals (Filer)
Form EFFECT
02/09/2021
2:52 PM
Oramed Pharmaceuticals (Subject)
Slager David Mark (Filed by)
Form SC 13G/A
02/08/2021
4:31 PM
Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:30 PM
KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:29 PM
Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2021
4:29 PM
Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2021
3:51 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2021
3:11 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/02/2020
7:43 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2020
4:23 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2020
4:14 PM
Oramed Pharmaceuticals (Filer)
Form 424B5
11/24/2020
6:37 AM
Oramed Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
10/22/2020
3:05 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2020
3:05 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/09/2020
3:13 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2020
3:33 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2020
3:39 PM
Oramed Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/15/2020
8:16 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2020
3:13 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/30/2020
3:09 PM
Oramed Pharmaceuticals (Filer)
Form DEF 14A
06/16/2020
3:28 PM
Oramed Pharmaceuticals (Filer)
Form PRE 14A
04/09/2020
3:42 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
3:46 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/02/2020
10:44 AM
Oramed Pharmaceuticals (Filer)
Form 424B5
02/28/2020
12:10 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
7:03 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
10:54 AM
Altium Capital Management LP (Filed by)
Oramed Pharmaceuticals (Subject)
Form SC 13G/A
02/11/2020
10:46 AM
Oramed Pharmaceuticals (Subject)
Slager David Mark (Filed by)
Form SC 13G
02/10/2020
11:15 PM
Oramed Pharmaceuticals (Filer)
Form EFFECT
02/10/2020
4:28 PM
Oramed Pharmaceuticals (Filer)
Form 424B5
01/21/2020
1:40 PM
Oramed Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/14/2020
3:08 PM
Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:07 PM
Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:06 PM
Mayer Arie (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:06 PM
KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:05 PM
Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:04 PM
Oramed Pharmaceuticals (Issuer)
Xiaoming Gao (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2020
3:04 PM
Friedman Aviad (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2020
2:57 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/27/2019
3:26 PM
Oramed Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/12/2019
6:04 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
3:35 PM
Oramed Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
09/16/2019
5:08 PM
Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
5:07 PM
KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
5:07 PM
Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
5:06 PM
Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
5:04 PM
Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2019
5:02 PM
Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/11/2019
4:17 PM
Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2019
3:49 PM
Oramed Pharmaceuticals (Filer)
Form 424B5
09/05/2019
3:41 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2019
4:27 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
12:29 PM
Oramed Pharmaceuticals (Filer)
Form DEF 14A
07/29/2019
5:07 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/19/2019
11:11 AM
Oramed Pharmaceuticals (Issuer)
Xiaoming Gao (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/18/2019
12:31 PM
Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
6:02 PM
Oramed Pharmaceuticals (Issuer)
Sank Leonard (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
4:26 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/01/2019
2:18 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
3:20 PM
Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2019
3:23 PM
Gabay Avraham (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2019
4:09 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/16/2019
4:01 PM
Oramed Pharmaceuticals (Issuer)
Slager David Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2019
4:00 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2019
4:07 PM
Oramed Pharmaceuticals (Issuer)
RAKIN KEVIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
4:21 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/28/2019
3:56 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2019
4:00 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
3:17 PM
Altium Capital Management LP (Filed by)
Oramed Pharmaceuticals (Subject)
Form SC 13G/A
01/14/2019
4:20 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/07/2019
8:01 AM
Oramed Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
12/14/2018
7:04 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
4:16 PM
Oramed Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/20/2018
3:58 PM
Hasleton Mark Daniel (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/08/2018
4:02 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2018
10:59 AM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2018
3:51 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2018
3:32 PM
Friedman Aviad (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2018
4:15 PM
Oramed Pharmaceuticals (Filer)
Form DEF 14A
07/20/2018
4:25 PM
Oramed Pharmaceuticals (Subject)
Slager David Mark (Filed by)
Form SC 13D/A
07/20/2018
4:17 PM
KIDRON NADAV (Filed by)
Oramed Pharmaceuticals (Subject)
Form SC 13D/A
07/12/2018
4:18 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/12/2018
4:11 PM
KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2018
3:57 PM
ARMISTICE CAPITAL, LLC (Filed by)
Oramed Pharmaceuticals (Subject)
Form SC 13G
07/05/2018
3:32 PM
Oramed Pharmaceuticals (Filer)
Form 424B5
07/05/2018
3:10 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
8:58 AM
Oramed Pharmaceuticals (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G
05/07/2018
3:51 PM
Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2018
9:55 AM
Oramed Pharmaceuticals (Filer)
Form CT ORDER
04/10/2018
4:41 PM
Hexter Joshua (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2018
4:14 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/20/2018
1:04 PM
Oramed Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/02/2018
4:36 PM
Eisenberg Hilla (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2018
4:34 PM
KIDRON NADAV (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2018
4:32 PM
Kidron Miriam (Reporting)
Oramed Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2018
12:09 PM
Oramed Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/29/2017
4:23 PM
Oramed Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.